THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth -10.5% ·
share flow -5.5% ·
net new positions -11.8%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 138 | +1 | 64.57M | $12.08B | +9 | −8 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.13M | -4.5% | $900.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.13M | -4.5% | $900.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 2.99M | — | $377.35M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Glenview Capital ✦ | 2.84M | +6.7% | $358.13M | 9.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.12M | +3.5% | $268.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 2.12M | +3.5% | $268.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.77M | -2.3% | $223.91M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 1.51M | -5.4% | $190.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 1.02M | +1971.8% | $128.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 1.02M | +1971.8% | $128.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 872.12K | +20.8% | $110.09M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 872.12K | +20.8% | $110.09M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 872.12K | +20.8% | $110.09M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 872.12K | +20.8% | $110.09M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 499.56K | -32.5% | $63.06M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 438.56K | +579.1% | $55.36M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 410.43K | -61.9% | $51.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 407.19K | +225.4% | $51.40M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 257.94K | +134.0% | $32.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 251.15K | -84.3% | $31.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 251.15K | -84.3% | $31.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 222.22K | -28.1% | $28.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 114.18K | +58.1% | $14.41M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 24 | Harris Associates (Oakmark) ✦ | 3.40K | -12.8% | $429,182 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $73.62M | was 0.3% |
| Greenlight Capital (DME… | $47.72M | was 2.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 686 holders, 81.68M shares, $13.63B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 2.50K sh · $652,075
Director · 4.92K sh · $1.30M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology